60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP NASDAQ) stock market data APIs
$0.8992
-0.02(-2.2%)
as of October 15, 2026
Try our APIs with
free plan!
60 Degrees Pharmaceuticals, Inc. Common Stock Financial Data Overview
Price chart is built with
Anychart
60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. It offers Arakoda for malaria prevention treatment. The company also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19 indications; Tafenoquine, which is in phase IIA clinical trials for babesiosis, fungal and pneumocystis pneumonias, and candidiasis disease; and Celgosivir for Zika, respiratory viruses, and dengue fever. It also has patent license agreement with Tufts Medical Center to jointly advance the development and commercialization of tafenoquine for the treatment and prevention of babesiosis. 60 Degrees Pharmaceuticals, Inc. was founded in 2010 and is headquartered in Washington, District Of Columbia.
Prev. Close
0.8992
Open
0.8817
High
0.9003
Low
0.8374
52 wk Range
0.835-6.24
Market Cap
3 096 K
Shares Outstanding
3 517 K
Revenue
1 215 K
EPS
-0.9
Beta
2.396
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get 60 Degrees Pharmaceuticals, Inc. Common Stock data using free add-ons & libraries
Get 60 Degrees Pharmaceuticals, Inc. Common Stock Fundamental Data
60 Degrees Pharmaceuticals, Inc. Common Stock Fundamental data includes:
- Net Revenue: 1 215 K
- EBITDA: -8 504 303
- Earnings Per Share: -5
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get 60 Degrees Pharmaceuticals, Inc. Common Stock Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-08-14
- EPS/Forecast: -0.74
Get 60 Degrees Pharmaceuticals, Inc. Common Stock End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
60 Degrees Pharmaceuticals, Inc. Common Stock News
New
Merck KGaA (MKKGY) Misses Q2 Earnings Estimates
Merck KGaA (MKKGY) came out with quarterly earnings of $0.26 per share, missing the Zacks Consensus Estimate of $0.47 per share. This compares to earnings of $0.57 per share a year ago. These figures ...
60 Degrees Pharmaceuticals, Inc. Announces Private Placement Priced At-the-Market Under Nasdaq Rules
WASHINGTON, July 30, 2026 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP, SXTPW) (“60 Degrees” or the “Company”), a pharmaceutical company that develops and commercialize...
60 Degrees Pharma Signs FSU Deal To Advance Castanospermine For Tick-Borne Diseases
(RTTNews) - 60 Degrees Pharmaceuticals, Inc. (SXTP), which develops treatment for vector-borne disease, announced that it has entered into an exclusive option agreement with the Florida State Universi...
60 Degrees' Phase 2 B-Free Babesiosis Study Of ARAKODA Clears Safety Board Review
(RTTNews) - 60 Degrees Pharmaceuticals, Inc. (SXTP), a pharmaceutical company, on Wednesday announced that an independent Data Safety Monitoring Board has recommended continuing its Phase 2 B-Free chr...
Get 60 Degrees Pharmaceuticals, Inc. Common Stock fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.